Clinical Trial Update: Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the safety and potential efficacy of ctDNA MRD-guided escalation of adjuvant therapy after definitive chemoradiotherapy in unresectabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Esophageal Cancer, MRD | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION